FLT1 and breast cancer: Inhibition of VEGFR1 can inhibit angiogenesis in mouse models of breast cancer and decrease the viability of various breast cancer cell lines such as CAL-120, JIMT-1, MCF-7, and MDA-MB-134 [87].